This 124-page report provides assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for hemostasis testing.
The report also includes strategic assessments of current and emerging suppliers of hemostasis products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 124 pages